The hallmark of Crohn's disease (CD) is systemic inflammation, along with intestinal inflammation that extends through all layers of the gut wall. Hyperbaric Oxygen (HBOT) has been shown to cause a significant reduction in the inflammatory markers in CD while also showing clinical improvements in these patients. Emerging evidence suggests that gut microbiota plays a predominant role in in CD and is associated with the progression of CD. Since HBOT has been shown to regulate gut microbiota, this study was aimed to observe the effects in CD. Their findings demonstrated that HBOT was able to mitigate the altered composition of gut microbiota and improve the reduced microbial diversity found in CD.  By regulating the gut micorbiota, HBOT was able to help ameliorate intestinal inflammation along with systemic inflammation.<view study>     Read Less

The Researchers of this study previously documented that Hyperbaric Oxygen therapy (HBOT) was able to help provide "significant improvements in cognitive, psychiatric, fatigue, sleep, and pain symptoms" for those individuals suffering from Long COVID syndrome (LCS) In this follow up study, researchers wanted to determine if the reported benefits were long-lasting, so they required a full 40 hour couses of HBOT along with a one-year minimum follow up evaluation for all participants. The follow up results confirmed that alll the clinical improvements gained by HBOT were persistent even 1 year after the last HBOT session"<view study> Read Less

This study included a group of fibromyalgia-diagnosed w0men taking a full course of 40 hyperbaric oxygen sessions at 1.45 ATA (90 minutes per session, 5 days per week, for a total of 8 weeks). Follow up results showed significant improvements in pain threshold <view study> Read Less

A 61-year-old right-handed male stoke patient was suffering from hemiparesis and physical weakness in the right upper limb for 2 years. He then underwent a course of hyperbaric oxygen therapy (HBOT) for 60 daily sessions at 2.0 ATA. Each session was 90 minutes and included two 5-minute air breaks. Following this simple 3 month course of HBOT, both clinical and objective hand motor improvements were observed and documented though functional brain imaging scans comparing both pre and post HBOT. From the fMRI data collected, researchers of this study were able to conclude that “HBOT induces brain plasticity and functional improvement in chronic post-stroke patients” <view study> Read Less

An estimated 15.1% of individuals suffer from Long Covid Syndrome (LCS) 3 months following severe SARS-CoV-2 infection, with symptoms continuing past 12 months. LCS symptoms commonly include persistent fatigue, mood swings, body pain, cognitive impairment, and ongoing respiratory problems. Other persistent symptoms can include headaches, mental disorders, gut issues, insomnia, hair loss, and smell/taste dysfunction. Treatment options are limited to symptomatic measures, and no specific medication has been established. Previous studies have shown that just 10 sessions of HBOT at 2.4 ATA caused a statistically significant improvement of fatigue, global cognition, executive function, attention, information processing and verbal function. In this study, 18 patients (aged 18-90) were given a short course of 10 hyperbaric sessions at 2.2 ATA and were followed up 3 months later for evaluation of LCS. The results were very promising and documented significant improvements in energy levels, physical functioning, emotional well being, social functioning and improvement in limitation of activities <view study> Read Less